Market Cap 10.53M
Revenue (ttm) 0.00
Net Income (ttm) -19.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 441,700
Avg Vol 461,372
Day's Range N/A - N/A
Shares Out 45.78M
Stochastic %K 48%
Beta 0.29
Analysts Strong Sell
Price Target $2.90

Company Profile

Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads in...

Industry: Biotechnology
Sector: Healthcare
Phone: 929 274 7510
Fax: 929 274 7553
Address:
22 Boston Wharf Road, Floor 7, Boston, United States
RisingMoons
RisingMoons Mar. 4 at 9:12 PM
0 · Reply
RisingMoons
RisingMoons Mar. 4 at 9:07 PM
0 · Reply
SirHoppington
SirHoppington Feb. 24 at 7:17 PM
$AKTX nice
0 · Reply
stockscan
stockscan Feb. 23 at 1:59 PM
$AKTX https://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-present-2026-biocom-global-partnering
0 · Reply
stockscan
stockscan Feb. 23 at 1:58 PM
$AKTX https://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-appoints-globally-recognized-expert-rna
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 20 at 1:09 AM
$AKTX RSI: 52.44, MACD: -0.0138 Vol: 0.02, MA20: 0.24, MA50: 0.27 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PaulLaurent
PaulLaurent Feb. 18 at 9:32 PM
📊🧵 Highest Short Interest Update 💥📛 $XHG $AKTX $ZSL $PPBT $AREB
0 · Reply
Digitalization2026
Digitalization2026 Feb. 13 at 10:01 PM
Last call before we leave! 🚂 🚂 After Hours Top Gainers PT 2 $BRTX $ZNB $AKTX $NCI 🚨 $CETX — Upcoming Catalysts Loading 🚨 Everyone waits for confirmation… then chases. Price is still sitting near key levels, but catalysts are stacking: earnings update, backlog progress, integration of recent acquisitions, potential new contracts. This company is not what it was a year ago. Multi-segment revenue (security, industrial, aerospace/defense), improving operations, real assets — not just a ticker. Low float + volume spike = fast moves. We’ve seen 100%+ runs happen quickly in setups like this. 🎯 Speculative Targets (NFA): $2$3 first leg $4$6 momentum breakout $8$12+ if growth + re-rating align Buy early or chase later — market doesn’t send invitations. Know your risk. 🚀
0 · Reply
topstockalerts
topstockalerts Feb. 13 at 9:54 PM
After Hours Top Gainers $LFS $BRTX $ZNB $AKTX $NCI
0 · Reply
a1pha2er0
a1pha2er0 Feb. 13 at 12:05 AM
$AKTX how much cash do they have? How much cash do they need to get to the first event that won’t be met with significant dilution within seconds of the announcement?
0 · Reply
Latest News on AKTX
Akari Therapeutics to Present at the 2026 Biotech Showcase

Jan 8, 2026, 9:15 AM EST - 7 weeks ago

Akari Therapeutics to Present at the 2026 Biotech Showcase


Akari Therapeutics Announces Launch of CEO Corner Platform

Oct 22, 2025, 9:05 AM EDT - 4 months ago

Akari Therapeutics Announces Launch of CEO Corner Platform


Akari Therapeutics Announces Key Leadership Appointments

Dec 18, 2024, 8:51 AM EST - 1 year ago

Akari Therapeutics Announces Key Leadership Appointments


RisingMoons
RisingMoons Mar. 4 at 9:12 PM
0 · Reply
RisingMoons
RisingMoons Mar. 4 at 9:07 PM
0 · Reply
SirHoppington
SirHoppington Feb. 24 at 7:17 PM
$AKTX nice
0 · Reply
stockscan
stockscan Feb. 23 at 1:59 PM
$AKTX https://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-present-2026-biocom-global-partnering
0 · Reply
stockscan
stockscan Feb. 23 at 1:58 PM
$AKTX https://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-appoints-globally-recognized-expert-rna
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 20 at 1:09 AM
$AKTX RSI: 52.44, MACD: -0.0138 Vol: 0.02, MA20: 0.24, MA50: 0.27 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PaulLaurent
PaulLaurent Feb. 18 at 9:32 PM
📊🧵 Highest Short Interest Update 💥📛 $XHG $AKTX $ZSL $PPBT $AREB
0 · Reply
Digitalization2026
Digitalization2026 Feb. 13 at 10:01 PM
Last call before we leave! 🚂 🚂 After Hours Top Gainers PT 2 $BRTX $ZNB $AKTX $NCI 🚨 $CETX — Upcoming Catalysts Loading 🚨 Everyone waits for confirmation… then chases. Price is still sitting near key levels, but catalysts are stacking: earnings update, backlog progress, integration of recent acquisitions, potential new contracts. This company is not what it was a year ago. Multi-segment revenue (security, industrial, aerospace/defense), improving operations, real assets — not just a ticker. Low float + volume spike = fast moves. We’ve seen 100%+ runs happen quickly in setups like this. 🎯 Speculative Targets (NFA): $2$3 first leg $4$6 momentum breakout $8$12+ if growth + re-rating align Buy early or chase later — market doesn’t send invitations. Know your risk. 🚀
0 · Reply
topstockalerts
topstockalerts Feb. 13 at 9:54 PM
After Hours Top Gainers $LFS $BRTX $ZNB $AKTX $NCI
0 · Reply
a1pha2er0
a1pha2er0 Feb. 13 at 12:05 AM
$AKTX how much cash do they have? How much cash do they need to get to the first event that won’t be met with significant dilution within seconds of the announcement?
0 · Reply
DarkSonar
DarkSonar Feb. 11 at 5:29 PM
$AKTX This company is complete crap!! At $0.27 and they already have $0.38 warrants ready to exercise. Have more dilution prepped up and possibilities of delisting due cumulative R/S. Don’t get me wrong, the chart looks great but the obstacles make it a risk too high to take.
1 · Reply
pc247cz
pc247cz Feb. 11 at 2:41 PM
0 · Reply
KaylasPort
KaylasPort Feb. 10 at 1:07 PM
$AKTX catalysts today at 1 PM
0 · Reply
stockscan
stockscan Feb. 10 at 12:20 PM
$AKTX https://akaritx.com/2026/02/05/akari-therapeutics-to-participate-in-the-corporate-connect-webinar-series-virtual-conference-hosted-by-webull-financial/
0 · Reply
FlowTactix
FlowTactix Feb. 9 at 11:17 AM
$AKTX is a biotech (Akari Therapeutics) developing complement inhibitors; targeting rare inflammatory diseases offers high prices but requires demonstrating significant benefit in small, hard-to-run clinical trials.
0 · Reply
BigBull005
BigBull005 Feb. 6 at 7:43 PM
$AKTX Are there any OGs still holding or is it just newbies trying to scalp every one cent move? I have been so deep underwater on this ticker that I am honestly embarrassed to even look at it. Does anyone still have conviction here especially with the new management and the so called “miracle payload” that’s supposed to cure every cancer on the planet?
2 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 2 at 8:53 PM
$AKTX RSI: 34.75, MACD: -0.0234 Vol: 0.02, MA20: 0.27, MA50: 0.32 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
pc247cz
pc247cz Jan. 30 at 3:47 PM
$AKTX glad to see some life here. The volume is very low, as this current market is not very supportive of this kind of fragile and speculative plays.
0 · Reply
richeey
richeey Jan. 30 at 1:58 PM
$AKTX what ever happened to the ticks?
2 · Reply
MTN
MTN Jan. 29 at 6:46 PM
$AKTX going to 0. What a pathetic group of folks who accomplished nothing. Could have had a 1B+ company, squandered it.
0 · Reply
suitedandbooted
suitedandbooted Jan. 26 at 2:19 PM
$AKTX another bio low entry point for a swing ? Watching
0 · Reply
stockscan
stockscan Jan. 26 at 1:50 PM
$AKTX https://investor.akaritx.com/news-releases/news-release-details/akari-therapeutics-files-key-patent-and-unveils-second-adc
0 · Reply